Skip to main content . The types of samples include: Saliva samples are collected by spitting into a tube rather than using a nose or throat swab. A few weeks ago, a ProPublica reporter decided to test his kids for COVID-19. Click here for a full list of FDA approved at-home COVID tests and their up-to-date expiration dates. Appendix J - Sample Updated Fact Sheet for Health Care Providers, Appendix K - Sample Updated Fact Sheet for Patients, EUA Letter of Authorization - Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing, Appendix L - Fact Sheet for Health Care Providers (Template), Appendix M - Fact Sheet for Patients (Template), Laboratories Who Have Developed a Molecular-Based Test (LDTs) for Coronavirus Disease 2019 (COVID-19), Orig3n 2019 Novel Coronavirus (COVID-19) Test, Biocollections Worldwide SARS-Co-V-2 Assay, Avera Institute for Human Genetics SARS-CoV-2 Assay, Real-time RT-PCR, Home Collection, Saliva, Multiple Targets, RT, LAMP, Over the Counter (OTC) Home Testing, Saliva, Screening, Multiple Targets, Real-time RT-PCR, Home Collection, Multiple Targets, Screening, Pooling, Laboratory Corporation of America (Labcorp), Direct to Consumer (DTC), Real-time RT-PCR, Multi-analyte, Home Collection, Single Target, End-Point RT-PCR, Screening, Multiple Targets, Home Collection Kit, Screening, Single Target, Real-time RT-PCR, Home Collection, Screening, Multiple Targets, RT, LAMP, Lateral Flow Strips, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Real-time RT-PCR, Multi-analyte, Multiple Targets, Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute, Real-time RT-PCR, Multi-analyte, Home Collection, Multiple Targets, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Direct to Consumer (DTC), Real-time RT-PCR, Saliva, Home Collection, Screening, Pooling, Single Target, Direct to Consumer (DTC), Home Collection Kit, Saliva, Screening, Real-time RT-PCR, Home Collection, Multiple Targets, The Mount Sinai Hospital, Center for Clinical Laboratories, Real-time RT-PCR, Home Collection, Saliva, Screening, Multiple Targets, Centers for Disease Control and Prevention's (CDC), Real-time RT-PCR, Pooling, Multiple Targets, Wadsworth Center, New York State Department of Public Health, RT-PCR and electrochemical detection, Single Target, Real-time RT-PCR, Home Collection, Pooling, Multiple Targets, Real-time RT-PCR, Home Collection, Pooling, Screening, Multiple Targets, Real-time RT-PCR, Pooling, Screening, Multiple Targets, RT, Nested multiplex PCR, Pooling, Saliva, Multiple Targets, Real-time RT-PCR, Pooling, Screening, Saliva, Multiple Targets, RT, Isothermal amplification, Single Target, RT-PCR, Collection Kit, Saliva, Multiple Targets, RT-PCR, CoPrimer technology, Single Target, Real-time RT-digital PCR, Multiple Targets, Real-time RT-PCR, Screening, Multiple Targets, RT, Isothermal amplification, Multiple Targets, RT-PCR, Home Collection, Saliva, Single Target, Fast Track Diagnostics Luxembourg S..r.l. STATEN ISLAND, N.Y. -- The U.S. Food and Drug Administration (FDA) is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories. Jonas Edward Salk (/ s l k /; born Jonas Salk; October 28, 1914 - June 23, 1995) was an American virologist and medical researcher who developed one of the first successful polio vaccines.He was born in New York City and attended the City College of New York and New York University School of Medicine.. Age 2 years and older when collected by an adult, Requires supervision of a telehealth proctor and a smartphone or computer, People with symptoms that began within the last 7 days, People without symptoms. The .gov means its official.Federal government websites often end in .gov or .mil. To date, however, no device has been added to the list of authorized devices in Appendix A of the letter of authorization. For information on tests that have been revoked see Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD). But the move came after tests last month showed the masks didn't meet standards. vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. The test is to be performed two times over three days (serial testing). The test is to be performed two times over three days (serial testing). In Vitro Diagnostic EUAs: Overview and Templates. Travel requirements to enter the United States are changing, starting November 8, 2021. There are two common types of COVID-19 diagnostic tests: Samples for COVID-19 diagnostic tests are typically collected using an anterior nares (nasal) swab sample. Accordingly, the EUA was revoked under Section 564(g)(2)(C) of the Federal Food, Drug, and Cosmetic (FD&C) Act. By taking these steps, the FDA and the test developer can quickly act in response to the potential risks identified and, when applicable, share the findings on SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. Jiangsu Bioperfectus Technologies Co., Ltd. This revision is effective as of September 23, 2021 for all EUAs that are within the scope of the revision. Some tests, including most antigen tests, can be performed completely at home, giving you results within minutes, without needing to send your sample to a laboratory. As set forth in the September 23, 2021 letter, developers of authorized tests that are within the scope of the revision are now required to routinely monitor emerging viral mutations and their potential impact on the performance of the authorized SARS-CoV-2 test(s). Qualitative detection of RNA from SARS-CoV-2 in pooled samples containing aliquots of transport media from up to [3, 5, or 10, depending on the applicable appendix] individual human anterior nasal swab specimens that were collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from any individual and placed in individual vials containing transport media, including individuals without symptoms or other reasons to suspect COVID-19, when tested as part of a serial testing program including testing at least once per week. Antigen multi-analyte respiratory panel tests authorized in the table below are assigned the QMN product code. Nelson Mullins cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. The latest Arizona headlines, breaking news, in-depth investigations, politics, and local community stories that matter to you. 2023, Charter Communications, all rights reserved. The FDA released an initial version of this infographicfor 2020. vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. For more information about how to reduce your risk of getting a false negative result on an at-home COVID-19 antigen test, read our FDA Safety Communication. An official website of the United States government, : On September 23, 2021, the FDA revised the EUAs of certain molecular, antigen, and serology tests to establish additional Conditions of Authorization in response to the continued emergence of new variants of SARS-CoV-2. Alternate brand name: GoodToKnow COVID-19 Antigen Rapid Test, Alternate brand name: GoToKnow COVID-19 Antigen Rapid Test, Alternate brand name: QuickFinder COVID-19 Antigen Self Test. {or self-collected at home using the following authorized home collection kit(s): [specific named home collection kit(s) with which the test was validated] when used consistent with the home collection kit's authorization for individuals tested at least once per week}, See Appendix A table below for a list of tests authorized under this EUA. Any test developer requesting an EUA that intends to leverage data from another developer's EUA-authorized device must obtain a right of reference to leverage the performance data for that EUA-authorized device. COVID-19 Tests and Collection Kits Authorized by the FDA The FDA is committed to helping ensure the public has access to a wide variety of test options for COVID-19. To see if the expiration date for your at-home OTC COVID-19 test has been extended, first find the row in the below table that matches the manufacturer and test name shown on the box label of your test. Coronavirus (COVID-19) and Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus (COVID-19) and Medical Devices, Counterfeit At-Home OTC COVID-19 Diagnostic Tests, At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions, Blood Specimen Collection Tube Shortage: Frequently Asked Questions, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Emergency Use Authorization of COVID-19 Tests: Independent Assessment of the FDAs Response, Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19, Medical Device Supply Chain Notifications During the COVID-19 Pandemic, Medical Device Shortages During the COVID-19 Public Health Emergency, Supplies of Medical Devices for COVID-19: Frequently Asked Questions, Medical Device Types to Help Determine Section 506J Notification Obligations, Non-contact Temperature Assessment Devices During the COVID-19 Pandemic, Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA) or Discussed in COVID-19-Related Guidance Documents, Contacts for Medical Devices During the COVID-19 Pandemic, COVID-19 Tests and Collection Kits Authorized by the FDA: Infographic, 63 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 32 pooling: Tests that process samples from multiple people at one time, 55 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 19multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 13 at-home: Tests performed at home with a self-collected sample, 38 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 18 pooling: Tests that process samples from multiple people at one time, 17 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 11 multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 3 at-home: Tests performed at home with a self-collected sample. Antibody (or serology) tests look for antibodies in your blood that your immune system produced in response to SARS-CoV-2, the virus that causes COVID-19. Before sharing sensitive information, make sure you're on a federal government site. The. For Test Name and Manufacturer: enter a single word (e.g., analyzer) or an exact phrase (e.g., acme analyzer). A COVID-19 test done with a sample of your blood (serology) only detects if your body has developed antibodies in response to the COVID-19 virus. Most authorized at-home OTC COVID-19 tests are antigen tests, and there are also a small number of authorized at-home OTC COVID-19 molecular tests. By taking these steps, the FDA and the test developer can quickly act in response to the potential risks identified and, when applicable, share the findings on SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. The site is secure. The tests detect different parts of the Covid virus and vary in sensitivity. Expired at-home COVID tests can lead to inaccurate or invalid test results, but medical experts say to think twice before throwing them away. As the number of people wanting to get tested for COVID-19 ahead of the holidays has spiked in recent days, many people have gone looking for an alternative that doesn't involve sitting in a line of cars for hours at a time. However, antibody test results are not reported on the state's dashboard anyway. The site is secure. To increase the accuracy of an at-home COVID-19 antigen diagnostic test, it is important to perform repeat testing, after 48 hours, following a negative test result, whether you have symptoms or not, to reduce your risk of a false negative test result. In some cases, the expiration date for a test may be extended. "There's a page on their website where you can look up by the name of the test, and see what that expiration date extension is," Humm said. 1. iHealth COVID-19 Rapid Antigen Test iHealth is another top-rated test brand that has an FDA-authorized at-home test kit for COVID-19. There are two common types of COVID-19 diagnostic tests: Molecular tests, such as polymerase chain reaction (PCR) and other nucleic acid amplification tests (NAATs) tests, which detect. Availability: This test is available online with or without a prescription, SELF explained previously.To get it, you'll first have to fill out a survey to make sure you meet the criteria for . This limits the test's effectiveness for diagnosing COVID-19, and this is one reason serology tests should not be used as the sole basis to diagnose COVID-19. If potential impacts are identified, the EUA holder must communicate with the FDA and end users about the potential risk that presence of the mutations may have on test performance. Before sharing sensitive information, make sure you're on a federal government site. The FDA encourages developers to discuss any alternative technological approaches to validating their test with the FDA through CDRH-EUA-Templates@fda.hhs.gov. On April 20, 2021, the FDA issued an amendment allowing certain authorized molecular diagnostic SARS-CoV-2 tests to be distributed and used to pool anterior nasal respiratory specimens from. These at-home OTC COVID-19 diagnostic tests are FDA authorized for self-testing at home (or in other locations). M - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. This article's lead section may be too long for the length of the article. Results are usually available in 30 minutes or less. (a Siemens Healthineers Company), Real-time RT-PCR, Screening, Pooling, Multiple Targets, Real-time RT-PCR, Home Collection, Saliva, Pooling, Multiple Targets, TMA, chemiluminescent, Pooling, Screening, Multiple Targets, Direct to Consumer (DTC), TMA, chemiluminescent, Home Collection, Screening, Pooling, Multiple Targets, RT, Isothermal amplification, Screening, Single Target. Also in May, it received EUA from the FDA for a molecular COVID-19 test for use on the company's Alinity molecular laboratory instrument. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. For details about each authorized COVID-19 diagnostic test, see the lists of authorized Molecular Diagnostic Tests and Antigen Diagnostic Tests, as well as the At-Home COVID-19 Diagnostic Tests webpage. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2, Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2, Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing, EUA for Molecular Diagnostic Tests for SARS-CoV-2 Developed And Performed By Laboratories Certified Under CLIA To Perform High Complexity Tests, Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Antigen EUA Revision for Serial (Repeat) Testing, Individual EUAs for Diagnostic Breath Tests for SARS-CoV-2, Individual EUAs for Genotyping Tests for SARS-CoV-2, Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Individual EUAs for Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic EUA Cover Sheet Template, Molecular Diagnostic Home Specimen Collection Template, Molecular and Antigen Home Use Test Template, Supplemental Template for Molecular and Antigen Diagnostic COVID-19 Tests for Screening with Serial Testing, Template for Serology Tests that Detect or Correlate to Neutralizing Antibodies, Policy for Coronavirus Disease-2019 Tests (Revised), Coronavirus (COVID-19) and Medical Devices, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. Authorized at-home OTC tests are available without a prescription and are typically available online or at local stores. Everything you need to know about Florida's theme parks and the all-new Attractions Insider podcast! In the table below, the "Expiration Date" column lists the shelf-life and where to find the expiration date for that test. Coronavirus (COVID-19) and Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus (COVID-19) and Medical Devices, Counterfeit At-Home OTC COVID-19 Diagnostic Tests, At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions, Blood Specimen Collection Tube Shortage: Frequently Asked Questions, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Emergency Use Authorization of COVID-19 Tests: Independent Assessment of the FDAs Response, Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19, Medical Device Supply Chain Notifications During the COVID-19 Pandemic, Medical Device Shortages During the COVID-19 Public Health Emergency, Supplies of Medical Devices for COVID-19: Frequently Asked Questions, Medical Device Types to Help Determine Section 506J Notification Obligations, Non-contact Temperature Assessment Devices During the COVID-19 Pandemic, Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA) or Discussed in COVID-19-Related Guidance Documents, Contacts for Medical Devices During the COVID-19 Pandemic, General Information About At-Home OTC COVID-19 Diagnostic Tests, List of Authorized At-Home OTC COVID-19 Diagnostic Tests, In Vitro Diagnostics EUAs: Tables of IVD EUAs, See link for list of updated expiration dates, Cue COVID-19 Test for Home and Over The Counter (OTC) Use, MaximBio ClearDetect COVID-19 Antigen Home Test, link for list of updated expiration dates, INDICAID COVID-19 Rapid Antigen At-Home Test, CLINITEST Rapid COVID-19 Antigen Self-Test, Speedy Swab Rapid COVID-19 Antigen Self-Test, Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results, At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative: FDA Safety Communication, COVID-19 Testing: What You Need to Know | CDC, COVID-19 Self-Testing At-Home or Anywhere | CDC, What to Do If You Were Exposed to COVID-19 | CDC, Isolation and Precautions for People with COVID-19 | CDC. Antibody tests should not be used to diagnose a current SARS-CoV-2 infection or COVID-19 and, at this time, should also not be used to check for immunity. Lab is submitting data to CalREDIE (either . On September 23, 2021, the FDA revised the EUAs of certain molecular, antigen, and serology tests to establish additional Conditions of Authorization in response to the continued emergence of new variants of SARS-CoV-2. Online, if you click to . Individuals ages 14 and older . Some antibody tests use blood samples from a finger stick. 263a, that meet requirements to perform moderate complexity tests. Most Food and Drug Administration approved at-home COVID tests have a longer lifespan than previously anticipated. Since August 9, 2022, the standard regimen has also been authorized for people aged <18 years under . The expiration date is set at the end of the shelf-life. Another way to find the updated list of expiration dates is on the FDA's website. FDA recommends repeating COVID-19 at-home test in 48 hours if negative The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after Headline CDC updates public health guidance for preventing COVID-19 illness On April 28, 2020, FDA issued an umbrella EUA for SARS-CoV-2 Antibody Tests (Lateral flow or Enzyme-linked immunosorbent assay (ELISA) tests) that have been evaluated in an independent validation study performed at the National Institutes of Health's (NIH) National Cancer Institute (NCI), or by another government agency designated by the FDA, and are confirmed by the FDA to meet the criteria set forth in the Scope of Authorization of the EUA. The FDA is actively researching the accuracy of at-home and self-test kits. 3 Abbreviations: CLIA = chemiluminescence immunoassay; ELISA = enzyme-linked immunosorbent assay; ECLIA = electrochemiluminescence immunoassay; FMIA = fluorescent microsphere Immunoassay, CMIA = chemiluminescent microparticle immunoassay; ELFA = enzyme-linked fluorescence assay. For three weeks . For more information about antibody testing, visit Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers. More information is available here. Once you've confirmed your vitamin D levels via testing, adjust your sun exposure and/or vitamin D3 supplementation accordingly. Most authorized at-home OTC COVID-19 tests are antigen tests, and there. USGC Saliva Test Kit, hims/hers Saliva Test Kit, AZOVA At-Home COVID-19 Test Collection Kit, Wellness 4 Humanity SDNA-1000 Saliva Collection Kit, AZOVA P23 At-Home COVID-19 Test Collection Kit, binx health (powered by P23) At-home Saliva COVID-19 Test Collection Kit for the Group Setting, Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2 . The announcement made Pfizer and BioNTech the first companies to develop and test a working vaccine for COVID-19. H - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate complexity tests. Blood samples are only used to test for antibodies and not to diagnose COVID-19. medical devices. On July 21, 2020, FDA determined, based on information and experience since issuing this EUA, that circumstances support revocation of this umbrella EUA so that FDA may issue individual EUAs. W - Patient care settings operating under a CLIA Certificate of Waiver. RT-PCR = reverse transcriptase polymerase chain reaction; LAMP = loop-mediated isothermal amplification; MALDI-TOF = Matrix Assisted Laser Desorption/Ionization - Time of Flight; TMA = Transcription Mediated Amplification; qSTAR = Selective Temperature Amplification Reaction; CRISPR = clustered regularly interspaced short palindromic repeats; Qualitative detection of RNA from SARS-CoV-2 in pooled samples containing up to [3, 5, or 10, depending on the applicable appendix] individual human anterior nasal swabs placed in a single vial containing transport media after being collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from any individual, including individuals without symptoms or other reasons to suspect COVID-19, when tested at least once per week as part of a serial testing program. Where a test was previously authorized for testing of symptomatic individuals (for example, within the first [number specific to each test] days of symptom onset), the test is now authorized for use at least twice over three days with at least 48 hours between tests. Find All FDA-Approved Home and Lab Tests You can find information about each home or lab test that FDA has approved or cleared by searching FDA's Database of In Vitro Diagnostic (IVD). The table below lists FDA-authorized at-home OTC COVID-19 diagnostic tests, and includes information on expiration dates, who can use the test, and other details that may help you decide what test is right for you. The test is to be performed two times over three days (serial testing). Qualitative detection of RNA from SARS-CoV-2 in individual human anterior nasal swab samples collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from individuals, including individuals without symptoms or other reasons to suspect COVID-19, when tested at least once per week. This action is in response to available data about the performance of COVID-19 antigen tests showing that repeat testing after a negative COVID-19 antigen test result increases the chance of an accurate result in people with and without symptoms and could help prevent people from unknowingly spreading the SARS-CoV-2 virus to others. The November 1, 2022 revision requires test developers in the scope of the revision to take certain actions, including submitting a supplemental EUA request to the FDA with updated labeling to reflect the revised authorized uses, as follows: Repeat Testing Revision Letter - November 1, 2022, An official website of the United States government, : KOMU 8 ORAL) saliva collection devices, Express Gene 2019-nCoV RT-PCR Diagnostic Panel, Gravity Diagnostics SARS-CoV-2 RT-PCR Assay, Pixel by LabCorp COVID-19 Test Home Collection Kit, Letter Granting EUA Revision(s) (April 1, 2022), Letter Granting EUA Revision(s) (July 8, 2022), Letter Granting EUA Revision(s) (November 1, 2022), Letter Granting EUA Revision(s) (February 12, 2021), Letter Granting EUA Revision(s) (November 17, 2021), Letter Granting EUA Revision(s) (February 24, 2021), Letter Granting EUA Revision(s) (February 14, 2023), Letter Granting EUA Revision(s) (March 9, 2021), Letter Granting EUA Revision(s) (March 25, 2021), Letter Granting EUA Revision(s) (May 5, 2022), Letter Granting EUA Revision(s) (April 30, 2021), Bio-Rad Reliance SARS-CoV-2 RT-PCR Assay Kit, Letter Granting EUA Revision(s) (March 3, 2021), BD MAX COVID-19 ASSAY (Authorized by HHS/OASH), PMSF-INNO SARS-CoV-2 RT-PCR Test (Authorized by HHS/OASH), Letter Granting EUA Revision(s) (March 4, 2022), Gravity Diagnostics SARS-CoV-2 RT-PCR for use with DTC kits, Everlywell COVID-19 Test Home Collection Kit DTC, Cue COVID-19 Test for Home and Over The Counter (OTC) Use, Letter Granting EUA Revision(s) (June 10, 2021), Letter Granting EUA Revision(s) (July 1, 2021), Letter Granting EUA Revision(s) (February 7, 2022), Letter Granting EUA Revision(s) (March 30, 2022), NxTAG Respiratory Pathogen Panel + SARS-CoV-2, Letter Granting EUA Revision(s) (January 4, 2023), CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay (Version 3), Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2 -Amendment Letter, Gravity Diagnostics COVID-19 Test Home Collection Kit, Color COVID-19 Self-Swab Collection Kit DTC, Color SARS-CoV-2 RT-LAMP Diagnostic Assay DTC, NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay, Amazon Real-Time RT-PCR Test for Detecting SARS-CoV-2, Letter Granting EUA Revision(s) (December 17, 2021), SARS-CoV-2 real time RT-PCR test (Authorized by HHS/OASH), Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit, Letter Granting EUA Revision(s) (March 3, 2022), Letter Granting EUA Revision(s) (November 4, 2022), PerkinElmer SARS-CoV-2 RT-qPCR Reagent Kit, Clinical Enterprise SARS-CoV-2 RT-PCR Assay, Clinical Enterprise SARS-CoV-2 RT-PCR Assay DTC, Letter Granting EUA Revision(s) (May 6, 2021), Color COVID-19 Self-Swab Collection Kit with Saline, Letter Granting EUA Revision(s) (January 31, 2022), Letter Granting EUA Revision(s) (June 15, 2022), Biosearch Technologies SARS-CoV-2 Real-Time and End-Point RT-PCR Test, Letter Granting EUA Revision(s) (June 2, 2021), Kaiser Permanente High Throughput SARS-CoV-2 Assay, Pinpoint by Phosphorus COVID-19 Test Home Collection Kit DTC, WREN Laboratories COVID-19 Saliva Test Collection Kit DTC, cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System (cobas SARS-CoV-2), Everlywell COVID-19 & Flu Test Home Collection Kit, Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Revision(s) (September 21, 2022), Letter Granting EUA Revision(s) (October 22, 2021), Kwokman Diagnostics COVID-19 Home Collection Kit, Life Sciences Testing Center COVID-19 Test, Letter Granting EUA Revision(s) (March 25, 2022), Letter Granting EUA Revision(s) (August 2, 2022), Letter Granting EUA Revision(s) (September 9, 2022), Letter Granting EUA Revision(s) (November 8, 2022), Quest COVID-19 PCR Test Home Collection Kit, Letter Granting EUA Revision(s) (July 7, 2022), Letter Granting EUA Revision(s) (October 6, 2022), Test Yourself DC At-Home COVID-19 Collection Kit, Letter Granting EUA Revision(s) (May 25, 2022), OPTI SARS-CoV-2/ Influenza A/B RT-PCR Test (Version 1 and Version 2), Labcorp Seasonal Respiratory Virus RT-PCR Test, Letter Granting EUA Revision(s) (November 23, 2022), cobas SARS-CoV-2 Duo for use on the cobas 6800/8800 Systems, Diversified Medical Healthcare SARS-CoV-2 Assay, Hi-Sense COVID-19 Molecular Testing Kit 1.0, BD Respiratory Viral Panel for BD MAX System, LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete Assay, The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.